Roivant Sciences (ROIV) Other Operating Expenses (2020 - 2025)
Roivant Sciences (ROIV) posted Other Operating Expenses of $965000.0 for Q4 2025, up 769.37% on a QoQ basis from $111000.0 in Q3 2025, and up 36.69% year-over-year from $706000.0 in Q4 2024.
Roivant Sciences (ROIV) Other Operating Expenses (2020 - 2025) Analysis & Trends
Roivant Sciences' Other Operating Expenses history runs 6 years deep, the most recent figure standing at $965000.0 for Q4 2025.
- Quarterly Other Operating Expenses rose 36.69% year-over-year to $965000.0 in Q4 2025, while the trailing twelve-month figure through Mar 2026 was $1.2 million (up 6.68% YoY) and the FY2026 annual result came in at $1.3 million, up 41.05% from the prior year.
- Other Operating Expenses was $965000.0 for Q4 2025 at Roivant Sciences, up from $111000.0 in the prior quarter.
- Across five years, Other Operating Expenses topped out at $66.5 million in Q4 2021 and bottomed at $111000.0 in Q3 2025.
- A 5-year average of $10.8 million and a median of $909000.0 in 2021 frame the typical range for Other Operating Expenses.
- Annual changes were most pronounced in 2021 — Other Operating Expenses jumped 9618.13% — and 2024, when it tumbled 98.73%.
- Roivant Sciences' Other Operating Expenses stood at $66.5 million in 2021, then tumbled by 97.4% to $1.7 million in 2022, then surged by 1513.73% to $27.9 million in 2023, then plunged by 97.47% to $706000.0 in 2024, then jumped by 36.69% to $965000.0 in 2025.
- Business Quant data shows ROIV's Other Operating Expenses at $965000.0 in Q4 2025, $111000.0 in Q3 2025, and $154000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Roivant Sciences | 24.27 Bn | 24.27 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 965,000.00 |
| Sep 30, 2025 | 111,000.00 |
| Jun 30, 2025 | 154,000.00 |
| Dec 31, 2024 | 706,000.00 |
| Sep 30, 2024 | 234,000.00 |
| Jun 30, 2024 | 213,000.00 |
| Dec 31, 2023 | 27.85 Mn |
| Sep 30, 2023 | 14.17 Mn |
| Jun 30, 2023 | 16.71 Mn |
| Jun 30, 2022 | 1.73 Mn |
| Dec 31, 2021 | 66.47 Mn |
| Jun 30, 2021 | 853,000.00 |
| Dec 31, 2020 | 684,000.00 |
| Sep 30, 2020 | 715,000.00 |
| Jun 30, 2020 | 180,000.00 |